Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2026-03-26 Board/Management Inform…
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a filing to the Korean Financial Supervisory Service/Korea Exchange reporting the appointment, dismissal, or mid-term retirement of outside directors. This is a direct announcement of changes in the company’s board of directors (outside directors). Therefore, it falls under Board/Management Information.
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of the company’s 2026 Annual General Meeting, listing each agenda item, vote outcomes (approval status, percentages, counts), and details of resolutions (financial statements approval, dividend, director appointments). This matches the “Declaration of Voting Results & Voting Rights Announcements” category rather than materials (AGM-R) or other filings.
2026-03-26 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Kukje Pharma Co., Ltd. (국제약품주식회사) covering the fiscal years 2024 and 2025. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is the formal audit report issued by an external accounting firm (Daesung Accounting Corp), which is distinct from a 10-K (which is a broader regulatory filing) or an Earnings Release. Therefore, it is classified as an Audit Report. FY 2025
2026-03-18 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Kukje Pharma. It provides the audit opinion, financial highlights (assets, liabilities, equity, profit/loss), and auditor information. While it contains financial data, it is a standard regulatory disclosure announcement in the Korean market (DART/KIND system) confirming the receipt and submission of the audit report, rather than the full annual report document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2025
2026-03-17 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation) used to request shareholder votes for an upcoming Annual General Meeting (AGM). It contains information about the meeting agenda, proxy voting procedures, and financial summaries. This falls under the 'Proxy Solicitation & Information Statement' category.
2026-03-04 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Kukje Pharm Co., Ltd. It contains the meeting agenda, details on voting procedures (including electronic voting), board activity reports, and financial highlights for the 68th fiscal year. This document is a standard proxy statement/notice of meeting sent to shareholders to solicit votes for the upcoming AGM, which falls under the 'Proxy Solicitation & Information Statement' category.
2026-02-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.